Search Results

CLOUT Registry Begins Enrollment for Inari's ClotTriever Thrombectomy System

September 27, 2018—Inari Medical, Inc. announced the enrollment of the first patient in the ClotTriever Outcomes Registry CLOUT using the company's ClotTriever thrombectomy system.

Acera Surgical’s Restrata Studied for the Treatment of Venous Leg Ulcers

February 10, 2022—Acera Surgical, Inc., a developer of fully synthetic materials for regenerative medical applications, announced commencement of patient enrollment in a clinical study evaluating the company’s Restrata for the treatment of nonhealing venous leg ulcers (VLUs).

InterVene’s Recana Thrombectomy System Cleared by FDA

November 6, 2025—InterVene, Inc. recently announced that it has received 510(k) clearance from the FDA for its Recana thrombectomy catheter system, which is designed specifically for venous in-stent restenosis and native vessel obstructions.

SonoVascular SonoThrombectomy System FIH Study Presented With Initial Results

March 27, 2025—SonoVascular, Inc. recently announced it has successfully completed an initial set of eight cases in patients with deep vein thrombosis (DVT) in its first-in-human (FIH) study of the SonoThrombectomy system for venous thromboembolism treatment.

Funding Will Support Clinical Trials of InterVene's BlueLeaf System for Deep Vein Reflux

June 25, 2019—InterVene, Inc. announced that it has raised $15 million in a Series B financing round, which will support the development of the company’s BlueLeaf endovenous valve formation system, which is a catheter-based solution for deep vein reflux (DVR).

InterVene’s BlueLeaf Endovenous Valve Formation System Granted FDA Breakthrough Device Designation

December 13, 2021—InterVene Inc. announced that it has received Breakthrough Device designation from the FDA for the company’s BlueLeaf endovenous valve formation (EVF) system.

Study Explores Early Thrombosis After Iliac Stenting for Venous Outflow Occlusion

November 19, 2021—The Society for Vascular Surgery (SVS) announced the publication of findings from a study showing that extended use (> 10 days) of low-molecular-weight heparin (LMWH) after stenting for extensive iliofemoral venous occlusion before transition to oral anticoagulation reduces early thrombosis.

Study Evaluates Endovenous Thermal Ablation for Chronic Venous Insufficiency

June 15, 2017—The Society for Vascular Surgery (SVS) announced the publication of new evidence that suggests that minimally invasive methods to ablate superficial venous reflux in patients with end-stage venous insufficiency are as effective as traditional open venous stripping.